Latin America R&D eyes "bioscience bridge" to EU
This article was originally published in Clinica
Spain is brokering collaborations with leading research bodies in Argentina, Chile and Mexico, in the hope of launching projects under the aegis of the European Union's healthcare R&D programmes.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.